Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 14 August 2020 |
| Author/s |
author: Jennifer R Diamond Joyce O'Shaughnessy Cynthia Osborne |
| Publication date | August 14, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |